The Proposed Rule states that payments from insurers (as defined) are to be excluded from the AMP calculation. With many of these insurers now partnering with retail community pharmacies (example: Safeway will dispense product to Express Scripts members), is it CMS’ intention that manufacturers should back out those transactions and payments from their retail sales within their AMP calculations? If it is or still an open issue, I would request that CMS keep in mind the difficulty this may pose for manufacturers and complications this would add to their calculations.
CA--Professional Provider Services
This is comment on Proposed Rule
Medicaid Program: Covered Outpatient Drugs
View Comment
Related Comments
View AllPublic Submission Posted: 03/02/2012 ID: CMS-2012-0012-0004
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/14/2012 ID: CMS-2012-0012-0007
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/28/2012 ID: CMS-2012-0012-0008
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/28/2012 ID: CMS-2012-0012-0009
Apr 02,2012 11:59 PM ET
Public Submission Posted: 03/28/2012 ID: CMS-2012-0012-0010
Apr 02,2012 11:59 PM ET